Healthcare & Life Sciences
Karuna Therapeutics
United Stateswww.karunatx.com
Karuna Therapeutics is a startup based in the United States, most recent round Series-c-plus, 3 tracked investors.
activeseries-c-plus
series-c-plus
Stage
2015
Founded
3
Investors
About Karuna Therapeutics
Karuna Therapeutics is a company founded in 2015 headquartered in the United States. Its most recent tracked round is Series-c-plus. Brouky records 3 investors associated with the company.
Karuna Therapeutics is a biopharmaceutical company developing therapies for neuropsychiatric disorders; its lead product KarXT (marketed as Cobenfy) is an FDA-approved muscarinic receptor-targeting treatment for schizophrenia in adults.
Explore Karuna Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.